Vaults and telomerase are ribonucleoprotein (RNP) particles that share a common protein subunit, TEP1. Although its role in either complex has not yet been defined, TEP1 has been shown to interact with the mouse telomerase RNA and with several of the human vault RNAs in a yeast three-hybrid assay. An mTep1−/− mouse was previously generated which resulted in no apparent change in telomere length or telomerase activity in six generations of mTep1-deficient mice. Here we show that the levels of the telomerase RNA and its association with the telomerase RNP are also unaffected in mTep1−/− mice. Although vaults purified from the livers of mTep1−/− mice appear structurally intact by both negative stain and cryoelectron microscopy, three-dimensional reconstruction of the mTep1−/− vault revealed less density in the cap than previously observed for the intact rat vault. Furthermore, the absence of TEP1 completely disrupted the stable association of the vault RNA with the purified vault particle and also resulted in a decrease in the levels and stability of the vault RNA. Therefore, we have uncovered a novel role for TEP1 in vivo as an integral vault protein important for the stabilization and recruitment of the vault RNA to the vault particle.
Skip Nav Destination
Article navigation
8 January 2001
Article|
January 08 2001
The Telomerase/Vault-Associated Protein Tep1 Is Required for Vault RNA Stability and Its Association with the Vault Particle
Valerie A. Kickhoefer,
Valerie A. Kickhoefer
aDepartment of Biological Chemistry and Jonsson Comprehensive Cancer Center, Crump Institute for Molecular Imaging, University of California at Los Angeles, School of Medicine, Los Angeles, California 90095
Search for other works by this author on:
Yie Liu,
Yie Liu
cOntario Cancer Institute/Amgen Institute, Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Lawrence B. Kong,
Lawrence B. Kong
bDepartment of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, University of California at Los Angeles, School of Medicine, Los Angeles, California 90095
Search for other works by this author on:
Bryan E. Snow,
Bryan E. Snow
cOntario Cancer Institute/Amgen Institute, Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Phoebe L. Stewart,
Phoebe L. Stewart
bDepartment of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, University of California at Los Angeles, School of Medicine, Los Angeles, California 90095
Search for other works by this author on:
Lea Harrington,
Lea Harrington
cOntario Cancer Institute/Amgen Institute, Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Leonard H. Rome
Leonard H. Rome
aDepartment of Biological Chemistry and Jonsson Comprehensive Cancer Center, Crump Institute for Molecular Imaging, University of California at Los Angeles, School of Medicine, Los Angeles, California 90095
Search for other works by this author on:
Valerie A. Kickhoefer
aDepartment of Biological Chemistry and Jonsson Comprehensive Cancer Center, Crump Institute for Molecular Imaging, University of California at Los Angeles, School of Medicine, Los Angeles, California 90095
Yie Liu
cOntario Cancer Institute/Amgen Institute, Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Lawrence B. Kong
bDepartment of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, University of California at Los Angeles, School of Medicine, Los Angeles, California 90095
Bryan E. Snow
cOntario Cancer Institute/Amgen Institute, Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Phoebe L. Stewart
bDepartment of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, University of California at Los Angeles, School of Medicine, Los Angeles, California 90095
Lea Harrington
cOntario Cancer Institute/Amgen Institute, Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Leonard H. Rome
aDepartment of Biological Chemistry and Jonsson Comprehensive Cancer Center, Crump Institute for Molecular Imaging, University of California at Los Angeles, School of Medicine, Los Angeles, California 90095
Abbreviations used in this paper: ES, embryonic stem; hTR, human telomerase RNA; MEF, mouse embryonic fibroblast; mTR, mouse telomerase RNA; MVP, major vault protein; mVR, mouse vault RNA; PARP, poly(ADP-ribose) polymerase; RT, reverse transcription; TERT, telomerase reverse transcriptase; TRAP, telomere repeat amplification procotol.
Received:
August 23 2000
Revision Requested:
November 02 2000
Accepted:
November 08 2000
Online ISSN: 1540-8140
Print ISSN: 0021-9525
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Cell Biol (2001) 152 (1): 157–164.
Article history
Received:
August 23 2000
Revision Requested:
November 02 2000
Accepted:
November 08 2000
Citation
Valerie A. Kickhoefer, Yie Liu, Lawrence B. Kong, Bryan E. Snow, Phoebe L. Stewart, Lea Harrington, Leonard H. Rome; The Telomerase/Vault-Associated Protein Tep1 Is Required for Vault RNA Stability and Its Association with the Vault Particle. J Cell Biol 8 January 2001; 152 (1): 157–164. doi: https://doi.org/10.1083/jcb.152.1.157
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement